Comprehensive Management of Cardiovascular Risk factors for adults with type 2 diabetes: a Scientific Statement from the American Heart Association
Similarly, mean changes in body weight were smaller: 5.3% (95% CI, 5.4% to 5.2%) for tirzepatide vs 3.3% (95% CI, 3.4% to 3.2%) for semaglutide at 3 months, 8.2% (95% CI, 8.4% to 8.0%) for tirzepatide vs 5.0% (95% CI, 5.1% to 4.8%) for semaglutide at 6 months, and 11.4% (95% CI, 12.0% to 10.8%) for tirzepatide vs 6.2% (95% CI, 6.7% to 5.8%) for semaglutide at 12 months
It slows gastric emptying, reduces appetite, and helps regulate blood sugar
Because the similar side effects of these medications, we may see a shift in the popularity of these drugs as more clinicians are educated on tirzepatide showing more promising impacts on weight loss and blood sugar management